Drug class
25-hydroxyvitamin D3; vitamin D prohormone and precursor of calcitriol
Mechanism of action
Calcifediol (25-hydroxyvitamin D3) is converted in the kidney and other tissues to 1,25-dihydroxyvitamin D (calcitriol), which activates the vitamin D receptor and regulates calcium, phosphate and parathyroid hormone homeostasis.
General use cases
- Treatment of secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease and vitamin D insufficiency using the extended-release formulation; immediate-release products may have different vitamin D deficiency indications
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
